Reference
- Hirsh J, Dalen JE, Deykin D, et al. Oral an ticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 1995; 108(4 Suppl): 231–46S
- Brigden ML. Oral anticoagulant therapy: newer indications and an improved method of monitoring. Postgrad Med 1992; 91(2): 285–96
- Hirsh J, Poller L. The International Normalized Ratio: a guide to understanding and correcting its problems. Arch Intern Med 1994; 154: 282–8
- Andrews TC, Peterson DW, Doeppenschmidt D, et al. Complications of warfarin therapy monitored by the International Normalized Ratio versus the prothrombin time ratio. Clin Cardiol 1995; 18(2): 80–2
- Khamashta MA, Cuadrado MJ, Mujic F, et al. The management of thrombosis in the antiphospholipid-antibody syndrome. N Engl J Med 1995; 332(15): 993–7
- Brigden ML. When bleeding complicates oral anticoagulant therapy: how to anticipate, investigate, and treat. Postgrad Med 1995: 98(3): 153–65
- Fihn SD, McDonell M, Martin D, et al. Risk factors for complications of chronic anticoagulation: a multicenter study. Ann Intern Med 1993; I18(7): 511–20
- Landefeld CS, Beyth RJ. Anticoagulant-related bleeding: clinical epidemiology, prediction, and prevention. Am J Med 1993: 95(3): 315–28
- Gladman JR, Dolan G. Effect of age upon the induction and maintenance of anticoagulation with warfarin. Postgrad Med J 1995: 71(833): 153–5
- Litin SC, Gastineau DA. Current concepts in anticoagulant therapy. Mayo Clin Proc 1995; 70(3): 266–72
- Hirsh J. Optimal intensity and monitoring warfarin. Am J Cardiol 1995; 75: 39–42B
- Bussey HI. How to monitor the dosage of warfarin. Heart Dis Stroke 1993; 2(5): 388–92
- Hathaway WE, Goodnight SH Jr. Disorders of hemostasis and thrombosis: a clinical guide. New York: McGraw-Hill, Health Professions Division, 1993: 497
- Lassen JF, Brandslund I, Antonsen S. International normalized ratio for prothrombin times in patients taking oral anticoagulants: critical difference and probability of significant change in consecutive measurements. Clin Chem 1995; 41(3): 444–7
- Kumar S, Haigh JR, Rhodes LE, et al. Poor compliance is a major factor in unstable outpatient control of anticoagulant therapy. Thromb Haemost 1989; 62(2): 729–32
- Booth SL, Sadowski JA, Weihrauch JL. Vitamin K, (phylloqui-none) content of foods: a provisional table. J Food Composition Analysis 1993; 6: 109–20
- Chow WH, Chow TC, Tse TM, et al. Anticoagulation instability with life-threatening complication after dietary modification. Postgrad Med J 1990; 66: 855–7
- O'Reilly RA. Lack of effect of mealtime wine on the hypoprothrom- binemia of oral anticoagulants. Am J Med Sci 1979; 277(2): 189–94
- White RH, McKittrick T, Hutchinson R, et al. Temporary discontinuation of warfarin therapy: changes in the International Normalized Ratio. Ann Intern Med 1995; 122(1): 40–2
- Wilcox CM, Truss CD. Gastrointestinal bleeding in patients receiving long-term anticoagulant therapy. Am J Med 1988; 84(4): 683–90
- Sternberg ML, Pettyjohn FS. Warfarin sodium-induced skin necrosis. Ann Emerg Med 1995; 26(1): 94–7
- Hyman BT, Landas SK, Ashman RF, et al. Warfarin-related purple toes syndrome and cholesterol microembolization. Am J Med 1987: 82(6): 1233–7